-
Fellowship within the laboratory of Dr Ed Boas, at the Beckman Research Institute of City of Hope. For more information on his research please visit here . We are looking for a biomedical engineer, materials
-
of the Division of Epigenetics and Transcriptional Engineering at City of Hope Cancer Center. His lab investigates epigenetic mechanisms of drug resistance and identifies therapeutic targets in various
-
Associate III (QCA III) to support in-process and release testing for GMP Manufacturing and gene and cellular immunotherapy products. This fast-paced lab uses cutting-edge technology for clinical
-
transduction, ELISA, CART production, CRISPR/Cas9 technology · In vivo skills: o Routes of drug administration: oral gavage, intraperitoneal, retro-orbital, subcutaneous, or tail vein injections o
-
well as disease relapse in order to design novel inhibitors to intervene the malignancies; 3) collaborative analyses of myeloid cancers genomics using high-throughput single-cell technology. The group conducts
-
labs involved in cutting edge technology, research, and clinical immunotherapeutic programs. Dr. Lior Goldberg’s lab currently has an opening for a Postdoctoral Fellow who will develop chimeric antigen
-
-process and release testing of GMP Manufacturing and analytical development for cellular immunotherapy products. This is a fast-paced lab involved in cutting edge technology, research and clinical cellular
-
seeking a Research Associate II to join the T Cell Therapeutics Research Laboratory. This role involves fast-paced research in cutting-edge technology, immunotherapeutic programs, and a commitment to
-
qualifications: Bachelor’s or Master’s degree in molecular biology, cell biology, engineering, biology, chemistry, or related field. Tissue culture with cell lines and primary cells. Molecular biology techniques
-
labs involved in cutting edge technology, research, and clinical immunotherapeutic programs. Dr. Lior Goldberg’s lab currently has an opening for a Postdoctoral Fellow who will develop chimeric antigen